References
- Bartnik M, Malmberg K, Norhammar A, et al. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J. 2004;25(22):1990–1997.
- Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 1999;48(5):937–942.
- Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010;375(9716):735–742.
- Fonseca V, Sharma PP, Shah M, et al. Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension. Curr Med Res Opin. 2011;27(4):799–807.
- Ibanez B, James S, Antunes MJ, ESC Scientific Document Group, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–177.
- World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Korean Med Assoc. 2014;57(11):899–902.
- Kim O-J, Park YH, Hyun BG. Development of the codes and guidelines of medical ethics in Korea. J Korean Med Assoc. 2017;60(1):8–17.
- Ministry of Government Legislation [Internet]. South Korea’s Bioethics and Safety Act; 2008. June. Available from: http://www.moleg.go.kr/english/korLawEng?pstSeq=47518.
- Fox CS, Golden SH, Anderson C, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diab Care. 2015;38(9):1777–1803.
- Jemberg T, Hasvold P, Henriksson M, et al. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. Eur Heart J. 2015;36(19):1163–1170.
- Wang Y, Li J, Zheng X, et al. Risk Factors associated with major cardiovascular events 1 year after acute myocardial infarction. JAMA Netw Open. 2018;1(4):e181079.
- Timmer JR, van der Horst IC, Henriques JP, et al. Long-term clinical outcome of ST-segment elevation myocardial infarction patients with and without diabetes mellitus in the Zwolle trial. Neth Heart J. 2003;11(10):387–393.
- Nesto RW, Zarich S. Acute myocardial infarction in diabetes mellitus. Circulation. 1998;97(1):12–15.
- Gibson CM, Ryan KA, Murphy SA, et al. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction. J Am Coll Cardiol. 1999;34(4):974–982.
- Gardner GS, Frisch DR, Murphy SA, et al. Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries. Am J Cardiol. 2004;94(2):178–181.
- Kosiborod M, Inzucchi SE, Krumholz HM, et al. Glucose normalization and outcome in patients with acute myocardial infarction. Arch Intern Med. 2009;169(5):438–446.
- Malmberg K, Rydén L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26((7):650–651.
- Cheung NW, Wong VW, McLean M. Hyperglycemia: intensive insulin infusion in infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care. 2006;29(4):765–770.
- Lee HR, Yu JM, Choi MG, et al. Risk factors for early development of macrovascular complications in Korea Type 2 diabetes. Korean Diabetes J. 2009;33(2):134–142.
- López-Sendón J, Swedberg K, McMurray J, et al. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J. 2004;25(15):1341–1362.
- Patti G, Cannon CP, Murphy SA, et al. Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies. Circulation. 2011;123(15):1622–1632.
- Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359(9324):2140–2144.
- Bronisz A, Kozinski M, Magielski P, et al. Value of oral glucose tolerance test in the acute phase of myocardial infarction. Cardiovasc Diabetol. 2011;10(1):21.
- Torabi A, Cleland JG, Rigby AS, et al. Development and course of heart failure after a myocardial infarction in younger and older people. J Geriatr Cardiol. 2014;11(1):1–12.